Introduction {#sec1}
============

Laparoscopic surgery is an approved technique in colorectal cancer treatment. Lower rates of perioperative complications and at least equal oncological results have been proven in randomised controlled trials and confirmed with meta-analyses \[[@cit0001], [@cit0002]\]. Despite technical improvements to abdominoperineal resection \[[@cit0003]\], over the last two decades there has been a significant shift in types of resections performed for rectal cancer treatment \[[@cit0004]\]. Improved surgical techniques and technology, introduction of neoadjuvant treatment, and better understanding of disease biology have increased the proportions of patients undergoing sphincter-preserving procedures and decreased the percentage of abdominoperineal amputations \[[@cit0005]\]. At the same time, functional and quality-of-life assessment studies have brought to light significant changes in those domains resulting from the applied treatments \[[@cit0006]\]. Symptoms include, but are not limited to, difficulties with flatus and stool control, urgency to defecate, loss of sensory functions, emptying problems, and many others \[[@cit0007]\]. Prevalence of those symptoms amongst low anterior resection patients differs between the studies depending on definitions of low anterior resection syndrome (LARS) or its components and sensitivity of applied measurement methodologies, but anything between 30% and 90% of patients may be involved. Different symptoms of low LARS have different effects on patients' wellbeing. One of the most debilitating components of LARS is faecal incontinence. This influences many aspects of patient functioning, which is reflected in quality-of-life changes, mainly in coping and embarrassment domains \[[@cit0008]\]. Some speculation has been made on the exact aetiology of LARS. Disruption of somatic and/or autonomic innervations \[[@cit0009]--[@cit0011]\] and changes in rectal reservoir functions due to alterations of rectal compliance or rectal ampulla volume have been suggested as possible causes \[[@cit0009], [@cit0012]\]. In addition, changes related to neoadjuvant treatment, probably mostly those attributed to radiotherapy, influence the functional results \[[@cit0013]--[@cit0015]\]. Loss of sensory function of the recto-anal transitory zone is also thought to influence discriminatory function and enhance the probability of faecal incontinence \[[@cit0016]\].

There is little difference between open and laparoscopic approaches in terms of rectal reservoir function, since this is dependent on anastomotic techniques and perhaps on the length of proximal resection, but there might be a difference in terms of preservation of neural structures. Key logic behind this speculation would be better visualisation and precision of dissection resulting from operating field exposure and magnification. Conversely, due to lower degrees of freedom, lack of tactile assessment and increased technical difficulty, it may be the case that laparoscopy increases the probability of LARS \[[@cit0017]\]. To date most data have referred to patients operated on with an open approach or mixed groups were analyzed. Moreover, perioperative protocols are leading to a change of traditional risk factors for postoperative complications \[[@cit0018]\]. Whether they bring benefits beyond hospital stay is still under debate.

Aim {#sec2}
===

In this study we decided to establish risk factors for LARS in patients undergoing laparoscopic total mesorectal excision (TME) for rectal cancer.

Material and methods {#sec3}
====================

Setting and design {#sec3.1}
------------------

Between 2014 and 2016, prospective data collection was performed in patients undergoing transabdominal resection for the treatment of rectal cancer. All procedures were performed in a tertiary-level university teaching hospital. The annual volume of colorectal procedures exceeds 120, and approximately 50 of those are performed for rectal cancer. Patients with histologically confirmed low and mid (\< 10 cm from the anal verge) rectal adenocarcinoma were included in the study and were submitted to neoadjuvant chemoradiotherapy when indicated. Each patient underwent evaluation of faecal continence twice (before any treatment and 6 months after the end of treatment) or three times when undergoing neoadjuvant radiotherapy. We used the Jorge-Wexner scale and LARS score for patient assessment: major LARS was defined as a LARS score \> 30; minor LARS was defined as a LARS score of 21--29 \[[@cit0019], [@cit0020]\]. Patients with any sort of faecal diversion at the time of the last evaluation (end colostomy, loop ileostomy) or those lost to follow-up were excluded from the study. All procedures were performed by the same surgical team, with the number of cases and conversion rates suggesting high placement on a learning curve \[[@cit0021]\]. Assessment of complications was performed using the Clavien-Dindo Classification, and we considered a Clavien-Dindo score of III--V to be a severe complication \[[@cit0022]\]. Each patient was treated with the standardized Enhanced Recovery after Surgery protocol with median compliance above 80% \[[@cit0023], [@cit0024]\].

Measured outcomes {#sec3.2}
-----------------

The primary outcome was the LARS score and Jorge-Wexner score at 6 months after surgical treatment \[[@cit0013], [@cit0020]\]. The secondary outcomes were the risk factors for LARS development.

Operative technique {#sec3.3}
-------------------

The surgical technique has been described elsewhere as nerve preserving total mesorectal excision \[[@cit0025]\]. The anastomosis was performed using a circumferential stapler. Protective ileostomy was created for all anastomoses in the ultra-low anterior resection group and selectively in the low anterior resection group.

Statistical analysis {#sec3.4}
--------------------

All data were analysed with Statistica version 13.0 PL (StatSoft Inc., Tulsa, OK, USA). The results are presented as mean, standard deviation (SD), median, and interquartile range (IQR). The study of categorical variables used the χ^2^ test of independence. The Shapiro-Wilk test was used to check for normal distribution of data, and Student's t test was used for normally distributed quantitative data. For non-normally distributed quantitative variables, the Mann-Whitney U test was used. A *p*-value \< 0.05 was considered statistically significant. All considerable patient- and treatment-related factors were analysed in univariate logistic regression models, then significant factors were analysed in the multiple logistic regression model in search of independent risk factors for LARS.

The study was approved by the local ethics committee. Each patient signed an informed consent form before inclusion in the study.

Results {#sec4}
=======

Eighty-three patients were eligible for the study. The group design is presented in [Figure 1](#f0001){ref-type="fig"}. Based on exclusion criteria, 56 patients were included in the study. Group characteristics and perioperative outcomes are shown in [Table I](#t0001){ref-type="table"}.

###### 

General characteristics and perioperative outcomes

  Parameter                                   Results                              
  ------------------------------------------- ------------------------------------ -------------
  Males/females                               28/28 (50%/50%)                      
  Age, mean ± SD, min.--max. \[years\]        61 ±11, 36--83                       
  BMI, median (IQR); min.--max. \[kg/m^2^\]   26.58 (24.04--29.71); 19.00--43.51   
  ASA 1, *n* (%)                              2 (3.57)                             
  ASA 2, *n* (%)                              50 (89.29)                           
  ASA 3, *n* (%)                              4 (7.14)                             
  Any significant comorbidity, *n* (%)        32 (57.14)                           
  Diabetes mellitus, *n* (%)                  11 (19.64)                           
  Arterial hypertension, *n* (%)              22 (39.29)                           
  Coronary artery disease, *n* (%)            15 (26.79)                           
  Renal comorbidity, *n* (%)                  2 (3.57)                             
  Hepatic comorbidity, *n* (%)                1 (1.79)                             
  Pulmonary comorbidity, *n* (%)              1 (1.79)                             
  T                                           0                                    3 (6%)
  1                                           2 (4%)                               
  2                                           10 (20%)                             
  3                                           31 (62%)                             
  4                                           4 (8%)                               
  N                                           0                                    34 (70.83%)
  1                                           6 (12.5%)                            
  2                                           8 (16.67%)                           
  AJCC                                        0                                    2 (3.57%)
  1                                           19 (33.93%)                          
  2                                           20 (35.71%)                          
  3                                           15 (26.79%)                          
  Radiotherapy                                23 (46.94%)                          
  Depth, median (IQR) \[cm\]                  10 (7--12)                           
  Depth                                       1                                    24 (42.86%)
  2                                           23 (41.07%)                          
  3                                           9 (16.07%)                           
  Bowel preparation                           37 (66.07%)                          
  Pre-op. drink                               48 (85.71%)                          
  Locoregional anaesthesia                    27 (58.70%)                          
  Laparoscopic low anterior resection         47 (83.93%)                          
  Laparoscopic ultra-low anterior resection   9 (16.07%)                           
  Ileostomy                                   22 (39.29%)                          
  Operative time, median (IQR) \[min\]        195 (140--240)                       
  Blood loss, median (IQR) \[ml\]             70 (50--150)                         
  Perioperative complications                 18 (32.14%)                          
  Clavien-Dindo classification                I                                    11 (19.64%)
  II                                          2 (3.57%)                            
  III                                         5 (8.93%)                            
  LOS, median (IQR) \[days\]                  5 (3--7)                             
  Readmissions                                4 (8.33%)                            
  Postoperative Wexner, median (IQR)          3 (0.5--8)                           
  Minor LARS                                  8 (14.29%)                           
  Major LARS                                  15 (26.79%)                          

![Study group design](WIITM-13-33245-g001){#f0001}

Fifteen (26%) patients developed major LARS and 10 (18%) patients had symptoms of minor LARS 6 months after surgery. The risk factors of LARS in univariate analysis were as follows: preoperative radiotherapy (OR = 11.9, 95% CI: 2.98--47.48, *p* \< 0.001); bowel preparation (OR = 6.27, 95% CI: 1.51--26.07, *p* = 0.01); ultra-low anterior rectal resection (OR = 17.07, 95% CI: 1.86--156.83, *p* = 0.01); and protective ileostomy creation (OR = 15.97, 95% CI: 4.07--61.92, *p* = 0.001). Greater distance of the tumour from the anal verge reduced the incidence of LARS (OR = 0.69, 95% CI: 0.55--0.86, *p* = 0.001). When multivariate analysis was performed, none of the analyzed factors turned out to be a major factor contributing to LARS development. A summary of our results is included in [Tables II](#t0002){ref-type="table"} and [III](#t0003){ref-type="table"}.

###### 

Factors influencing odds ratio for LARS

  Parameter                                                                            OR      95% CI         *P*-value
  ------------------------------------------------------------------------------------ ------- -------------- -----------
  Univariate:                                                                                                 
   Males vs. females                                                                   2.11    0.70--6.41     0.177
   Age                                                                                 0.98    0.93--1.03     0.364
   BMI                                                                                 0.95    0.84--1.08     0.448
   ASA                                                                                 0.55    0.09--3.22     0.499
   Comorbidity                                                                         0.71    0.24--2.13     0.531
   Diabetes mellitus                                                                   0.25    0.05--1.36     0.102
   Arterial hypertension                                                               1.35    0.44--4.09     0.592
   Coronary artery disease                                                             0.42    0.11--1.59     0.192
   Renal comorbidity                                                                   n/a                    
   Hepatic comorbidity                                                                 2.07    0.001--9.99    0.999
   Pulmonary comorbidity                                                               n/a                    
   T                                                                                   0.60    0.30--1.18     0.131
   N                                                                                   0.91    0.42--1.98     0.812
   AJCC                                                                                0.93    0.49--1.76     0.820
   Radiotherapy                                                                        11.9    2.98--47.48    \< 0.001
   Depth                                                                               0.69    0.55--0.86     0.001
   Bowel preparation                                                                   6.27    1.51--26.07    0.010
   Pre-op. drink                                                                       1.19    0.25--5.77     0.825
   Locoregional anaesthesia                                                            1.48    0.44--5.00     0.515
   Laparoscopic ultra-low anterior resection vs. laparoscopic low-anterior resection   17.07   1.86--156.83   0.010
   Vessels 2 vs. 1                                                                     1.12    0.34--3.73     0.852
   Ileostomy                                                                           15.87   4.07--61.92    \< 0.001
   Operative time                                                                      0.99    0.98--1.01     0.671
   Blood loss                                                                          0.99    0.98--1.00     0.127
   Perioperative complications                                                         1.71    0.54--5.47     0.352
   Clavien-Dindo                                                                       2.33    0.34--15.83    0.378
   LOS                                                                                 1.12    0.98--1.28     0.076
   Readmissions                                                                        4.33    0.39--48.00    0.220
  Multivariate:                                                                                               
   Radiotherapy                                                                        2.60    0.28--24.05    0.388
   Depth                                                                               1.89    0.51--7.03     0.330
   Bowel preparation                                                                   2.40    0.28--20.84    0.413
   Laparoscopic ultra-low anterior resection vs. laparoscopic low anterior resection   3.27    0.27--39.69    0.339
   Ileostomy                                                                           1.80    0.14--23.80    0.648

###### 

Regression models of parameters influencing postoperative Wexner score

  Parameter                                                                            Parameter ± SD   *P*-value
  ------------------------------------------------------------------------------------ ---------------- -----------
  Univariate:                                                                                           
   Males vs. females                                                                   --0.43 ±0.82     0.602
   Age                                                                                 --0.001 ±0.074   0.986
   BMI                                                                                 --0.343 ±0.171   0.050
   ASA                                                                                 --1.048 ±2.514   0.678
   Comorbidity                                                                         --0.198 ±0.827   0.812
   Diabetes mellitus                                                                   --1.170 ±1.019   0.256
   Arterial hypertension                                                               0.398 ±0.837     0.636
   Coronary artery disease                                                             --1.189 ±0.911   0.197
   Renal comorbidity                                                                   --0.833 ±2.204   0.707
   Hepatic comorbidity                                                                 --1.836 ±3.083   0.554
   Pulmonary comorbidity                                                               --0.309 ±3.093   0.921
   T                                                                                   1.747 ±0.803     0.035
   N                                                                                   --0.060 ±1.040   0.954
   AJCC                                                                                --0.199 ±0.959   0.836
   Radiotherapy                                                                        3.019 ±0.816     0.001
   Depth                                                                               --0.823 ±0.203   0.002
   Bowel preparation                                                                   1.734 ±0.832     0.042
   Pre-op. drink                                                                       --0.448 ±1.169   0.703
   Locoregional anaesthesia                                                            --0.640 ±0.897   0.479
   Laparoscopic ultra-low anterior resection vs. laparoscopic low-anterior resection   2.816 ±1.047     0.010
   Vessels 2 vs. 1                                                                     0.962 ±0.908     0.295
   Ileostomy                                                                           2.757 ±0.750     0.001
   Operative time                                                                      0.009 ±0.013     0.486
   Blood loss                                                                          --0.008 ±0.006   0.233
   Perioperative complications                                                         1.845 ±0.840     0.032
   3 vs. 2-1 Clavien-Dindo                                                             1.204 ±1.427     0.403
   Clavien-Dindo                                                                       1.289 ±0.868     0.143
   LOS                                                                                 0.211 ±0.163     0.201
   Readmissions                                                                        3.523 ±1.615     0.034
  Multivariate:                                                                                         
   Constant term                                                                       10.105 ±5.933    0.099
   T                                                                                   --1.212 ±0.942   0.208
   Radiotherapy                                                                        4.459 ±2.878     0.132
   Depth                                                                               --0.393 ±0.335   0.250
   Laparoscopic ultra-low anterior resection vs. laparoscopic low-anterior resection   1.379 ±2.346     0.561
   Ileostomy                                                                           --2.087 ±3.402   0.544
   Perioperative complications                                                         3.578 ±1.669     0.040
   Readmissions                                                                        6.696 ±2.902     0.028

The median Jorge-Wexner score after surgery was 3 points (IQR: 0--8, range: 0--18). The risk factors for a higher Jorge-Wexner score in univariate analysis were a higher T parameter in the TNM classification (*p* = 0.035), radiotherapy (*p* = 0.001), shorter distance of the tumour from the anal verge (*p* = 0.002), bowel preparation (*p* = 0.042), low anterior rectal resection (*p* = 0.01), ileostomy creation (*p* = 0.001), perioperative complications (*p* = 0.032) and readmission to the hospital within 30 days (*p* = 0.034). In multivariate analysis, readmissions and perioperative complications were a risk factors of a higher Jorge-Wexner score (*p* = 0.021 and *p* = 0.04, respectively).

Eighteen patients suffered from postoperative complications, including five considered severe (Clavien-Dindo III--V): three presented anastomotic leakage and two postoperative ileus. There were four 30-day readmissions due to late postoperative complications, none of which required surgical intervention. There were no mortalities within 30 days of the surgical procedure.

Discussion {#sec5}
==========

In our study we demonstrated that a laparoscopic approach is a safe and valuable tool for rectal resections in treatment of rectal cancer. However, 44% of patients developed minor or major LARS, which remains a high incidence rate.

Protective ileostomy was found to be a risk factor for LARS development after rectal resection, confirmed both in the LARS score and the Jorge-Wexner scale. This fact is rarely reported in the literature. Similar findings were presented by Jimenez-Gomez *et al.* \[[@cit0026]\]. Moreover, data from the LAARIS Trial Management Group indicate that a longer time from the initial procedure to ileostomy reversal increases LARS incidence \[[@cit0027]\]. That finding was not confirmed in the above-mentioned study by Jimènez-Rodriguez *et al.* \[[@cit0028]\]. Ileostomy creation decreases the rate of anastomotic leakage after rectal resections, although it may also increase the overall complication rate \[[@cit0029]\]. Therefore, the decision of ileostomy creation is even more challenging. Seeing that the literature data is inconsistent, further research in this field is needed. To date it seems that if ileostomy is performed it should be reversed within 6 months, since the LARS incidence in that case may be lower \[[@cit0027]\]. Moreover, there is evidence that very early ileostomy closure is beneficial and does not influence adjuvant treatment \[[@cit0030]--[@cit0032]\].

A novel finding in our study is that mechanical bowel preparation (MBP) is associated with increased risk of LARS. Although it was said that patients do not benefit from bowel preparation \[[@cit0033], [@cit0034]\], recently this opinion has been challenged again. Some new studies have shown that MBP combined with antibiotic preparation efficiently reduces perioperative complications in colorectal surgery \[[@cit0035]--[@cit0038]\]. These studies are, however, prone to selection bias -- patients in the no-MBP group were characterized by a higher comorbidity rate, more advanced stage of cancer, higher rate of renal and liver failure as well as more frequent steroid use. In addition, the most recent analysis based on the same registry data as previous analyses with propensity score matching confirmed that it is oral antibiotics rather than MBP that reduced complication rates \[[@cit0039]\]. Therefore if MBP seems to be ineffective and also may contribute to LARS development the decision to perform MBP should be carefully considered and well justified. Mechanical bowel preparation may be necessary when defunctioning ileostomy or transanal TME is planned; nonetheless van't Sant *et al.* questioned that hypothesis in a large multicenter study \[[@cit0040]\]. Also Pittet *et al.* suggested that rectal enema may successfully replace MBP \[[@cit0041]\]. Bearing in mind our results the decision of MBP is still uncertain and requires extensive investigation.

Perioperative radiotherapy is a risk factor of faecal incontinence 6 months after the surgery. Other authors also identified neoadjuvant radiotherapy as a factor leading to LARS \[[@cit0026], [@cit0042], [@cit0043]\]. Postoperative radiotherapy also causes deterioration of anal sphincter function \[[@cit0044], [@cit0045]\]. The effect of radiotherapy is not only clinically significant, but also is visible in manometric studies \[[@cit0046]\]. Nevertheless, radiotherapy significantly improves overall survival and disease-free survival, and thus the elimination of this part of modern treatment is not possible \[[@cit0047], [@cit0048]\]. However, more cautious selection of patients for preoperative radiotherapy should be performed in order to limit anal sphincter dysfunction.

A shorter distance from the anal verge and a larger size of the tumour are associated with LARS in the postoperative period. This is probably caused by the necessity of more extensive surgical techniques in order to gain proper resection margins. The type of the procedure (partial mesorectal excision vs. total mesorectal excision) is also considered as a risk factor of LARS \[[@cit0049]\].

Laparoscopic technique resulted in a lower LARS score according to Nuytens *et al.* \[[@cit0042]\]. In contrast, a meta-analysis performed by Lim *et al.* showed no difference between minimally invasive and open approaches regarding sexual and bladder functions \[[@cit0050]\]. There are few published studies comparing laparoscopic and open approaches in assessing long-term functional outcomes regarding anal sphincters. We had no open cases or conversions in our material, so such an analysis was impossible. Nevertheless the incidence of LARS in our material is comparable to other authors who use an open approach \[[@cit0049]\]. This suggests no superiority of minimally invasive techniques, but further investigations including RCTs are necessary.

Anastomosis with mechanical staplers reduces the incidence of LARS \[[@cit0043]\]. In our study, all anastomoses were performed using a mechanical stapler, so we cannot draw any conclusions regarding that variable.

Our study has some limitations, amongst which the relatively small number of included patients may result in a type II error. Moreover, we did not perform an analysis between LARS and time to ileostomy closure. Lastly, although some risk factors have been identified, they were not confirmed in the multivariate model, which is likely due to the limited number of cases or number of influencing variables leading to study group heterogeneity. Therefore, larger trials are needed in order to confirm our findings.

Conclusions {#sec6}
===========

In this study we were able to confirm that traditional risk factors for LARS are also present in laparoscopic rectal surgery. In addition, two new potential risk factors have been identified. Mechanical bowel preparation, being a part of perioperative care in rectal surgery, has been suggested to contribute to LARS development. In addition, defunctioning ileostomy may also have an impact on impaired function of the neorectum in the early postoperative period. However, due to the limitations of this study our observations require further confirmation in future trials.
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